These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11475329)

  • 1. Increased expression of metallothionein in inflammatory bowel disease.
    Brüwer M; Schmid KW; Metz KA; Krieglstein CF; Senninger N; Schürmann G
    Inflamm Res; 2001 Jun; 50(6):289-93. PubMed ID: 11475329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices.
    Ioachim E; Michael M; Katsanos C; Demou A; Tsianos EV
    Histol Histopathol; 2003 Jan; 18(1):75-82. PubMed ID: 12507286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein overexpression does not protect against inflammatory bowel disease in a murine colitis model.
    Oz HS; Chen T; de Villiers WJ; McClain CJ
    Med Sci Monit; 2005 Mar; 11(3):BR69-73. PubMed ID: 15735556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Annexin A2 expression in intestinal mucosa of patients with inflammatory bowel disease and its clinical implications].
    Zhang Z; Zhao X; Lv C; Li C; Zhi F
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1548-52. PubMed ID: 23174572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein: A Novel Therapeutic Target for Treatment of Inflammatory Bowel Disease.
    Dostie KE; Thees AV; Lynes MA
    Curr Pharm Des; 2018; 24(27):3155-3161. PubMed ID: 30014800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of metallothionein in murine experimental colitis.
    Tsuji T; Naito Y; Takagi T; Kugai M; Yoriki H; Horie R; Fukui A; Mizushima K; Hirai Y; Katada K; Kamada K; Uchiyama K; Handa O; Konishi H; Yagi N; Ichikawa H; Yanagisawa R; Suzuki JS; Takano H; Satoh M; Yoshikawa T
    Int J Mol Med; 2013 May; 31(5):1037-46. PubMed ID: 23467591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of metallothioneins as danger signals in the pathogenesis of colitis.
    Devisscher L; Hindryckx P; Lynes MA; Waeytens A; Cuvelier C; De Vos F; Vanhove C; Vos MD; Laukens D
    J Pathol; 2014 May; 233(1):89-100. PubMed ID: 24452846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
    Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I
    Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemically detectable metallothionein in granulation tissue surrounding mucosal ulceration.
    Douglas-Jones AG; Thomas ND; Elmes ME; Jasani B
    Histochem J; 1992 Jan; 24(1):40-50. PubMed ID: 1551798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a potential role of metallothioneins in inflammatory bowel diseases.
    Waeytens A; De Vos M; Laukens D
    Mediators Inflamm; 2009; 2009():729172. PubMed ID: 19727408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes.
    Buniatian GH; Hartmann HJ; Traub P; Wiesinger H; Albinus M; Nagel W; Shoeman R; Mecke D; Weser U
    Anat Rec; 2002 Aug; 267(4):296-306. PubMed ID: 12124908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.